[Substance use disorder in individuals with mild intellectual disabilities; collaboration needed]

Individuals with a mild intellectual disability or borderline intellectual functioning (mbid) are at risk for psychiatric disorders, including addictive disorders. Treatment of these disorders is often complicated by co-morbidity, as well as caregiver's and practitioner's struggle to effectively help.
AIM: To provide guidelines for psychiatrists to organize and deliver treatment to patients with mbid and addiction.
METHOD: Based on a case study, we describe obstacles in the care for patients with mbid and addiction, and provide guidelines to overcome these.
RESULTS: The Netherlands are leading in providing proper care for patients with mbid and addiction. However, available treatment protocols are not widely implemented.
CONCLUSION: Staff needs to be trained in working with patients with mbid and addiction, and interagency collaboration needs to be put in place. This is a collective responsibility of addiction medicine, general psychiatry, and disability services.